Medeor Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- November 27, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $57,000,000
Company Info
- Founders
- Steven Deitcher
- Company Description
- Medeor Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized cellular immunotherapies to improve outcomes in organ transplant recipients. Medeor's product candidates are designed to produce mixed chimerism to achieve donor-specific immune tolerance and improve patient outcomes.
- Market
- Organ Transplantation
- Location
- San Mateo, California, USA
- Coinvestors
- 6 Dimensions Capital, RA Capital Management, Sofinnova Ventures, Vivo Capital, WuXi Healthcare Ventures